Abstract:Background: Cervical intraepithelial neoplasia (CIN) is a collective term for pre-cancerous lesions associated with cervical invasive carcinoma. Treatment options depend on the development and progression of the disease. Especially for patients with CINII grade who are aged 25 years and older and have fertility requirements, it is a clinical challenge to determine whether to proceed with conservative or excisional treatment. Excisional treatment increases the risk of overtreatment outcomes, such as cervical insufficiency, preterm labor, miscarriage, and premature rupture of membranes, in young women with childbearing potential. P16 immunohistochemical staining has greatly improved the consistency of CINII patient's diagnosis. The aim of this study was to analyze the risk factors predicting pathological degradation after cervical excision in cervical intraepithelial neoplasia grade II P16-positive patients over 25 years old, and to provide information to help optimize clinical treatments patients with CINII disease. Methods: Single-factor and logistic regression models were used to analyze the risk factors for pathological downgrading in the CINII/P16-positive (+) group. The predicted probability of pathological downgrading in the CINII/P16(+) group of patients was calculated according to the logistic regression model to generate a new variable multi-indicator association for receiver operating characteristic (ROC) curve plotting to determine the predictive ability. Results: A total of 248 women who met the inclusion and exclusion criteria were included. Statistical analysis showed that the CINII/P16(+) group had a higher pathological downgrading rate compared with the CINIII group after cold knife conization (CKC) (χ2=6.26, P=0.012). Univariate factors showed that the differences were statistically significant when comparing age, number of biopsy-involved quadrants, menopausal status, and involvement of glands, respectively (P<0.05). In contrast, the differences were not statistically significant when comparing cytological findings, type of transformation zone, high-risk human papilloma virus (HR-HPV) testing, abortion status, pregnancy frequency, time from diagnosis to CKC and Ki67 percentage between the two groups. Multifactorial logistic regression showed that the extent of biopsy CINII involvement [odds ratio (OR), 1.589], menopausal status (OR, 4.031), and glandular involvement (OR, 5.549) were all independent risk factors for pathological downgrading in the CINII/P16(+) patient group (P<0.05). The order of significance of the areas under the ROC curve (AUCs) was as follows: combined multiple indicators (AUC 0.716) > gland involvement (AUC 0.625) > biopsy CINII involvement extent (AUC 0.614) > menopausal status (AUC 0.565). Conclusions: A higher rate of pathological downgrading after CKC was found in CINII/P16-positive patients who were aged over 25 years. Overtreatment exists in patients with CINII/P16-positive diagnosis. Independent factors for pathological downgrading were identified by the factors including if the lesion involved the gland, the extent of CINII involvement on biopsy, and menopausal status.

Cervical Intraepithelial Neoplasia grade 2 biopsy: Do p16INK4a and Ki-67 biomarkers contribute to the decision to treat? A cross-sectional study

Clinical Analysis of 72 Cases of Cervical Intraepithelial Neoplsia

Analysis of Factors Affecting the Prognosis of Patients with Cervical Intraepithelial Neoplasia 2

P16ink4a and Ki-67 Measurement Predict Progression of Cervical Low-Grade Squamous Intraepithelial Lesion.

Known Benefits and Unknown Risks of Active Surveillance of Cervical Intraepithelial Neoplasia Grade 2

The Accuracy of Diagnosing Cervical Intraepithelial Neoplasia with Colposcopically Directed Biopsy

Outcome of cervical intraepithelial neoplasia 2 diagnosed by punch biopsy in 131 women

Clinical and Pathological Analysis of 120 Cases Cervical Intraepithelial Neoplasia

P16ink4a Immunohistochemical Staining and Predictive Value for Progression of Cervical Intraepithelial Neoplasia Grade 1: a Prospective Study in China.

Classification of high-grade cervical intraepithelial neoplasia by p16ink4a , Ki-67, HPV E4 and FAM19A4/miR124-2 methylation status demonstrates considerable heterogeneity with potential consequences for management

Risk factors predicting pathological degradation after cervical excision in cervical intraepithelial neoplasia grade II P16-positive patients over 25 years old: a cross-sectional study

The Effect of P16/ki-67 and P16/mcm2 on the Detection of Cervical Intraepithelial Neoplasia: a Prospective Study from China

Role of DNA ploidy in diagnosis and prognosis of high-grade cervical intraepithelial neoplasia: A prospective cohort study

Prevalence of High-Grade Intraepithelial Neoplasia in Patients with Cytology Presenting Atypical Squamous Cells of Undetermined Significance

Biomarkers differentiating regression from progression among untreated cervical intraepithelial neoplasia grade 2 lesions

Correlation of Cervical Intraepithelial Neoplasia with Expressions of P16 and Ki67 in Exfoliated Cervical Cells in Fluid-Based Thin-Layer Samples.

Expression and Clinical Signiifcance of p16 and Ki-67 in Cervical Intraepithelial Neoplasia

Evaluation of Cervical High-Grade Squamous Intraepithelial Lesions-Correlated Markers as Triage Strategy for Colposcopy After Co-Testing

High-Grade Cervical Intraepithelial Neoplasia Detected By Colposcopy-Directed Or Random Biopsy Relative To Age, Cytology, Human Papillomavirus 16, And Lesion Size

Cervical Intraepithelial Neoplasia 2+ in Low-Grade Squamous Intraepithelial Lesion Pathologically Diagnosed by Colposcopy-Assisted Biopsy